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Abstract
Background  and  objectives:  A  review  of  all  the  adjuncts  for  intravenous  regional  anaesthesia
concluded  that  there  is  good  evidence  to  recommend  NonSteroidal  Anti-Inﬂammatory  agents
and  pethidine  in  the  dose  of  30  mg  dose  as  adjuncts  to  intravenous  regional  anaesthesia.  But
there  are  no  studies  to  compare  pethidine  of  30  mg  dose  to  any  of  the  NonSteroidal  Anti-
Inﬂammatory agents.
Methods: In  a  prospective,  randomized,  double  blind  study,  45  patients  were  given  intravenous
regional anaesthesia  with  either  lignocaine  alone  or  lignocaine  with  pethidine  30  mg  or  ligno-
caine  with  ketprofen  100  mg.  Fentanyl  was  used  as  rescue  analgesic  during  surgery.  For  the  ﬁrst
6  h  of  postoperative  period  analgesia  was  provided  by  fentanyl  injection  and  between  6  and  24  h
analgesia  was  provided  by  diclofenac  tablets.  Visual  analogue  scores  for  pain  and  consumption
of  fentanyl  and  diclofenac  were  compared.
Results:  The  block  was  inadequate  for  one  case  each  in  lignocaine  group  and  pethidine  group,
so general  anaesthesia  was  provided.  Time  for  the  ﬁrst  dose  of  fentanyl  required  for  post-
operative  analgesia  was  signiﬁcantly  more  in  pethidine  and  ketoprofen  groups  compared  to
lignocaine  group  (156.7  ±  148.8  and  153.0  ±  106.0  vs.  52.1  ±  52.4  min  respectively).  Total  fen-
tanyl  consumption  in  ﬁrst  6  h  of  postoperative  period  was  less  in  pethidine  and  ketoprofen  groups
compared  to  lignocaine  group  (37.5  ±  29.0  mcg,  38.3  ±  20.8  mcg  vs.  64.2  ±  27.2  mcg  respec-
tively). Consumption  of  diclofenac  tablets  was  2.4  ±  0.7,  2.5  ±  0.5  and  2.0  ±  0.7  in  the  control,
pethidine  and  ketoprofen  group  respectively,  which  was  statistically  not  signiﬁcant.  Side  effects
were  not  signiﬁcantly  different  between  the  groups.
 This work was conducted in the Department of Anesthesiology and Critical Care, All India Institute of Medical Sciences, New Delhi,
India.
 This article was presented as poster in International Congress on Regional Anaesthesia and Pain Medicine, New Delhi, February 20--22,
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Conclusion:  Both  pethidine  and  ketoprofen  are  equally  effective  in  providing  postoperative
analgesia up  to  6  h,  without  signiﬁcant  difference  in  the  side  effects  and  none  of  the  adjuncts
provide  signiﬁcant  analgesia  after  6  h.
© 2013  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  
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Estudo  comparativo,  randômico  e  duplo-cego  de  petidina  e  cetoprofeno  como
adjuvantes  de  lidocaína  em  anestesia  regional  intravenosa
Resumo
Justiﬁcativa  e  objetivos:  uma  revisão  de  todos  os  adjuvantes  para  anestesia  regional  intra-
venosa concluiu  que  há  boas  evidências  para  recomendar  os  agentes  anti-inﬂamatórios  não
esteroides  e  petidina  em  dose  de  30  mg  como  adjuvantes  para  anestesia  regional  intravenosa.
Porém, não  há  estudos  que  comparem  petidina  (30  mg)  com  quaisquer  dos  agentes  anti-
inﬂamatórios  não  esteroides.
Métodos: em  um  estudo  prospectivo,  randômico  e  duplo-cego,  45  pacientes  receberam  aneste-
sia  regional  intravenosa  com  apenas  lidocaína  ou  lidocaína  com  petidina  (30  mg)  ou  lidocaína
com cetoprofeno  (100  mg).  Fentanil  foi  usado  como  analgésico  de  resgate  durante  a  cirurgia.
Durante  as  seis  primeiras  horas  de  pós-operatório,  analgesia  foi  fornecida  via  injec¸ão  de  fen-
tanil  e,  entre  seis  e  24  horas,  analgesia  foi  fornecida  via  comprimidos  de  diclofenaco.  Os  escores
visuais  analógicos  para  dor  e  do  consumo  de  fentanil  e  diclofenaco  foram  comparados.
Resultados: o  bloqueio  foi  inadequado  para  um  caso  tanto  do  grupo  lidocaína  quanto  do
grupo petidina;  portanto,  anestesia  geral  foi  administrada.  O  tempo  para  a  primeira  dose
necessária  de  fentanil  para  analgesia  pós-operatória  foi  signiﬁcativamente  maior  nos  grupos
petidina  e  cetoprofeno  em  comparac¸ão  com  o  grupo  lidocaína  (156,7  ±  148,8  e  153,0  ±  106,0
vs.  52,1  ±  52,4  minutos,  respectivamente).  O  consumo  total  de  fentanil  nas  primeiras  seis  horas
de  pós-operatório  foi  menor  nos  grupos  petidina  e  cetoprofeno  em  comparac¸ão  com  o  grupo
lidocaína  (37,5  ±  29,0  mcg,  38,3  ±  20,8  mcg  vs.  64,2  ±  27,2  mcg,  respectivamente).  O  consumo
de  comprimidos  de  diclofenaco  foi  de  2,4  ±  0,7,  2,5  ±  0,5  e  2,0  ±  0,7  no  grupo  controle,  petid-
ina  e  cetoprofeno,  respectivamente,  o  que  não  foi  estatisticamente  signiﬁcante.  Os  efeitos
colaterais  não  foram  signiﬁcativamente  diferentes  entre  os  grupos.
Conclusão: tanto  petidina  quanto  cetoprofeno  são  igualmente  eﬁcazes  para  analgesia  pós-
operatória até  seis  horas,  sem  diferenc¸a signiﬁcante  nos  efeitos  colaterais,  e  nenhum  dos
adjuvantes  proporcionou  analgesia  signiﬁcativa  após  seis  horas.
© 2013  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  
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ntravenous  regional  anaesthesia  (IVRA)  is  safe  and  effec-
ive way  to  provide  anaesthesia  for  the  forearm  and  hand
urgeries lasting  up  to  90  min.  Main  limitations  to  its  use
re signiﬁcant  tourniquet  pain  during  surgery  and  lack  of
ostoperative analgesia.  To  overcome  these  problems  many
f adjuncts  drugs  have  been  used  along  with  local  anaes-
hetic agents  in  IVRA.  A  systemic  review  of  all  the  adjuncts
sed in  IVRA,  by  Choyce  and  Peng1 concluded  that  there  is
ood evidence  to  use  NonSteroidal  Anti-Inﬂammatory  agents
NSAIDs), particularly  ketorolac.  Among  the  opioids,  the
eview suggested  that  only  the  pethidine  in  a  dose  of  30  mg
as substantial  postoperative  beneﬁt,  but  at  the  expense  of
ost deﬂation  side  effects.  Ketoprofen  is  an  NSAID  available
n intravenous  formulation,  which  has  a  proven  efﬁcacy  in
roviding postoperative  analgesia  in  surgeries  such  as  tonsil-
ectomy, thyroid  and  nasal  surgeries.2--6 Dexketoprofen  has
een shown  to  provide  postoperative  analgesia  when  given
n IVRA,  compared  to  giving  it  intravenously.7 Aim  of  this
t
a
t
otudy  is  to  compare  ketoprofen  with  pethidine  30  mg  as
djunct to  lignocaine  in  IVRA.
ethods
fter  taking  approval  from  the  ethics  committee  of  the
nstitute and  informed  consent,  45  ASA  grade  I  and  II
atients posted  for  elective  forearm  and  hand  surgeries
ere selected  for  a  prospective,  randomized,  double  blind
tudy. All  the  patients  were  preoperatively  evaluated  and
isual analogue  score  for  pain  was  explained  to  them.
he patients  were  premeditated  with  intravenous  midazo-
am 1  mg,  10  min  before  the  procedure.  Routine  monitoring
ncluded ECG,  NIBP,  and  SpO2.  A  20  G  cannula  was  inserted
nd secured  in  a  distal  vein  of  the  arm  to  be  operated,  over
he dorsum  of  the  hand.  A  double-cuffed  tourniquet  was
pplied over  the  arm.  The  arm  was  exsanguinated  by  eleva-
ion and  application  of  Esmarch  bandage.  The  proximal  cuff
f  the  tourniquet  was  inﬂated  to  the  pressure  of  300  mm  Hg.
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Table  1  Demographic  data.
Gr-L  (n  =  14)  Gr-LP  (n  =  14)  Gr-LK  (n  =  15)  p  value
Age  (yr) 36.8 ±  5.6 33.4 ±  14.1  31.9  ±  16.6  0.68
Sex M/F  ratio  12/3  11/4  12/3  0.87
Weight (kg)  63.0  ±  8.1  64.7  ±  7.8  63.4  ±  8.5  0.83
Tourniquet time  (min)  64.6  ±  17.3  67.8  ±  16.6  76.1  ±  13.5  0.14
Surgical duration  (min)  47.8  ±  15.7  53.0  ±  14.9  56.9  ±  13.9  0.14
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Postoperative VAS  scores  were  comparable  between  the
groups. Time  for  the  ﬁrst  dose  of  fentanyl  consumption
was signiﬁcantly  delayed  in  groups  LP  and  LK  compared  to
Table  2  Tourniquet  pain  within  the  group.
Gr-LMean  rank  Gr-LPMean  rank  Gr-LKMean  rank
VAS15  1.6  1.7  1.9Isolation  of  the  limb  from  systemic  circulation  was
conﬁrmed by  observing  the  arm  for  the  absence  of  distended
veins and  conﬁrming  absence  of  radial  pulse.  The  Esmarch
bandage was  removed  and  40  mL  of  IVRA  solution  was
injected through  the  venous  cannula  slowly  over  a  period  of
90 s.
The  patients  were  randomly  divided  into  three  groups
of 15  each,  by  closed  envelope  technique.  They  received
either 40  mL  of  0.5%  lignocaine  (Gr-L)  or  40  mL  of  0.5%  lig-
nocaine along  with  pethidine  30  mg  (Gr-LP)  or  40  mL  of  0.5%
lignocaine along  with  ketoprofen  100  mg  (Gr-LK).
Pulse  rate,  blood  pressure,  and  SpO2 were  recorded  every
5 min.  Intra  operative  tourniquet  pain  was  assessed  every
15 min  using  visual  analogue  scale  of  0--10.  During  intra  oper-
ative period,  for  tourniquet  pain  (VAS  >  3)  25  mcg  of  fentanyl
was given  intravenously.  After  deﬂation  of  cuff,  pain  was
assessed using  VAS  scale  at  0,  15,  30,  60,  120,  180,  240  and
360 min.  For  early  postoperative  pain  up  to  6  h,  for  VAS  >  3,
bolus dose  of  fentanyl  25  mcg  was  given  intravenously.  Time
for ﬁrst  analgesic  consumption  and  total  number  of  fentanyl
boluses consumed  were  noted.
After  6  h  if  the  patient  had  pain,  patient  was  asked
to take  oral  tablet  of  diclofenac  50  mg.  The  patient
was asked  to  take  tablet  of  diclofenac  50  mg  every  8th
hour, if  pain  persisted.  Total  numbers  of  tablets  taken
in 24  h  were  noted  by  telephonic  interview.  Postopera-
tive nausea  and  vomiting,  pruritis,  tinnitus  and  dizziness
and respiratory  depression  (respiratory  rate  <10/min  or
SpO2 <  90%)  were  noted.  Sedation  was  noted  at  0,  30,  60  min
after the  deﬂation  of  tourniquet  using  a  numerical  scale
(1 =  completely  awake,  2  =  awake  but  drowsy,  3  =  asleep  but
responsive to  verbal  commands,  4  =  asleep  but  responsive  to
tactile stimulus,  5  =  asleep  and  not  responsive  to  any  stimu-
lus).
Data were  analyzed  using  SPSS  11.0  statistical  analysis
software. Ordinal  data  such  as  demographic  data,  tourni-
quet time,  surgical  duration,  haemodynamic  parameters
and number  of  diclofenac  tablets  consumed  were  compared
using one-way  ANOVA.  If  the  difference  was  statistically  sig-
niﬁcant, Schiff’s  post  hoc  analysis  was  performed.  Number
of patients  needing  fentanyl  during  intraoperative  period
and in  the  ﬁrst  6  h  of  postoperative  period  and  the  side
effects were  compared  using  Chi-square  test.  Continuous
data like  intraoperative  and  postoperative  pain  scores  and
sedation scores  within  the  groups  were  compared  with
Friedman rank  test.  The  pain  scores  and  sedation  scores
between the  groups  were  compared  using  Kruskal--Wallis
test. p  value  of  <0.05  was  considered  statistically
signiﬁcant.Figure  1  Intraoperative  VAS  scores.
esults
ne  patient  in  the  control  group  (Gr-L)  and  one  in  the  pethi-
ine group  (Gr-LP)  had  patchy  block  and  were  given  general
naesthesia. There  were  no  differences  among  the  groups
n demographic  variable,  tourniquet  time  and  surgical  dura-
ion (Table  1).  There  was  no  difference  between  groups  for
aemodynamics parameters  (heart  rate,  systolic  and  dia-
tolic blood  pressure).
Within each  group  VAS  scores  increased  progressively
rom 15  to  90  min  (Fig.  1).  In  order  to  ﬁnd  out,  when  the
ourniquet pain  became  signiﬁcant,  Friedman  test  (rank
est) was  (Table  2)  within  each  of  these  groups.  Tourniquet
ain increased  signiﬁcantly  between  30  and  45  min  in  all  the
roups. The  VAS  scores  were  comparable  between  the  groups
uring surgery.  Fentanyl  requirement  for  treatment  of  intra
perative tourniquet  pain  was  not  signiﬁcant  between  the
roups.VAS30 1.8  1.8  2.0
VAS45 3.0  2.7  2.7
VAS60 3.5  3.5  3.3
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Figure  2  Time  for  the  ﬁrst  analgesic  consumption.
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Figure  3  Fentanyl  requirement  in  ﬁrst  6  h  of  postoperative
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secondary hyperalgesia  reduce  both  early  and  late  post-
operative pain.10 Ketoprofen  is  a  NSAID  agent  available  ineriod.
roup  L  (156.7  ±  148.8  and  153.0  ±  106.0  vs.  52.1  ±  52.4  min
espectively) (Fig.  2).  Total  fentanyl  consumption  in  ﬁrst  6  h
f postoperative  period  (Fig.  3)  was  lesser  in  Gr-LP  and  Gr-
K compared  to  Gr  L  (37.5  ±  29.0  mcg,  38.3  ±  20.8  mcg  vs.
4.2 ±  27.2  mcg  respectively)  (Table  3).Number  of  diclofenac  tablets  consumed  between  6  and
4 h  was  not  signiﬁcantly  different  between  the  groups
i
i
Table  3  Time  and  doses  of  analgesics  consumed.
Gr
Time  for  ﬁrst  analgesic  (min)  52
Fentanyl used  in  ﬁrst  6  h  (mcg)  64
Number of  diclofenac  tablet  consumed  between  6  and  24  h  2
Table  4  Side  effects  proﬁle.
Gr-L  (n  =  14)  
Tinnitus,  dizziness  1  
Postoperative nausea  and  vomiting  0  
Pruritus 0  
Sedation score  1.20  ±  0.1  S.N.  Desai,  M.C.B.  Santhosh
2.4  ±  0.7,  2.5  ±  0.5,  2.0  ±  0.7  in  Gr-L,  Gr-LP,  Gr-LK  respec-
ively).
One patient  in  the  control  group,  four  patients  in  pethi-
ine group  and  two  patients  in  ketoprofen  had  tinnitus  and
izziness. Only  one  patient  in  pethidine  had  postoperative
ausea and  vomiting  and  none  of  patients  in  control  or
etoprofen had  PONV.  Two  patients  in  ketoprofen  group,
ut none  in  pethidine  or  control  group  had  pruritus.  None
f these  side  effects  were  statistically  signiﬁcant  between
he groups.  None  of  the  patients  in  any  group  had  sig-
iﬁcant respiratory  depression.  Sedation  scores  were  not
igniﬁcantly different  between  the  groups  (mean  scores  of
.2 ±  0.1,  1.1  ±  0.1,  1.4  ±  0.1  for  groups  L,  LP  and  LK  respec-
ively) (Table  4).
iscussion
e  found  that  the  addition  of  pethidine  or  ketoprofen  as
djuncts in  IVRA  provides  signiﬁcantly  better  postoperative
nalgesia in  the  ﬁrst  6  h.  However  their  efﬁcacy  postopera-
ive analgesia  is  limited  beyond  6  h.  Addition  of  either  of  the
djuncts does  not  increase  the  tourniquet  tolerance  when
ompared to  the  control  group.
At  the  site  of  surgical  trauma  there  will  be  release
f inﬂammatory  mediators  such  as  histamine,  serotonin,
radykinins and  metabolites  of  cycloxygenase  and  lipoox-
genase pathways.8 NSAIDs  inhibit  the  production  of
rostaglandins from  arachidonic  acid  in  the  phospholipid
embrane.9 Pretreatment  of  the  extremity  with  NSAIDs
ight be  expected  to  interfere  with  the  initiation  of  pain.
y preventing  the  synthesis  of  mediators  prior  to  sur-
ical trauma,  NSAIDs  might  minimize  the  activation  of
r sensitization  of  peripheral  nociceptors.  Although  the
oncept of  pre-emptive  analgesia  is  controversial,  evi-
ence from  the  animal  studies  supports  the  theory  that
reaking the  link  between  surgical  trauma  and  primary  orntravenous preparation.  It  has  proven  efﬁcacy  in  provid-
ng postoperative  analgesia  in  tonsillectomy,  thyroid  and
-L  (n  =  14)  Gr-LP  (n  =  14)  Gr-LK  (n  =  15)  p  value
.1  ±  52.4  156.7  ±  148.8  153.0  ±  106.0  0.02
.2  ±  27.2  37.5  ±  29.0  38.3  ±  20.8  0.01
.4  ±  0.7  2.5  ±  0.5  2.0  ±  0.7  0.08
Gr-LP  (n  =  14)  Gr-LK  (n  =  15)  p  value
4  2  0.23
1  0  0.31
0  2  0.15
1.133  ±  0.1  1.4  ±  0.1  0.70
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The analgesic effect of lornoxicam when added to lido-
caine for intravenous regional anaesthesia. Br J Anaesth.
2006;97:408--13.
13. Stein C, Yassouridis A. Peripheral morphine analgesia. Pain.
1997;71:119--21 [editorial].Comparison  of  pethidine,  ketoprofen  as  adjuncts  in  IVRA  
nasal  surgeries.2--6 The  NSAIDs  have  already  been  shown
to be  of  deﬁnitive  advantage  when  used  as  adjuncts  in
IVRA. NSAIDs  used  in  previous  studies  are  ketorolac  and
tenoxicam.11 Lornaxicam  when  used  as  adjunct  to  lignocaine
provided better  analgesia  compared  to  the  control.12 Simi-
larly dexketoprofen  as  additive  to  lignocaine  has  been  shown
to provide  good  postoperative  analgesia  compared  to  giv-
ing the  same  drug  intravenously  or  when  compared  to  the
placebo.7
Peripheral  action  of  opioids  could  be  mediated  by  either
peripheral opioid  receptors  or  by  local  anaesthetic  action
of their  own.13 Many  opioids  (morphine,  pethidine,  fen-
tanyl, tramadol,  sufentanil  and  alfentanil)  have  been  used
as adjuncts  in  IVRA  previously.  Among  these  opioids,  only
pethidine in  the  dose  above  30  mg  has  substantial  postop-
erative beneﬁts  but  at  the  expense  of  post  deﬂation  side
effects.1
There  are  no  studies  to  compare  pethidine  of  30  mg  dose
to any  of  NSAIDs.  So  the  aim  of  our  study  was  to  compare
pethidine in  a  dose  of  30  mg  with  a  NSAID,  ketoprofen  with
respect to  efﬁcacy  and  side  effects.
Previous  studies  have  suggested  30  mg  as  the  optimal
dose of  pethidine  as  an  adjuncts  in  IVRA.14 Optimum  dose
of ketorolac  for  use  as  adjuncts  in  IVRA  was  determined  as
twenty milligrams.11 Since  twenty  milligrams  of  ketorolac
is equipotent  to  100  mg  of  ketoprofen,  we  used  100  mg  of
ketoprofen in  our  study.
In  our  study  there  was  no  signiﬁcant  difference  in  the
intraoperative fentanyl  consumption  and  intraoperative  VAS
scores for  the  tourniquet  pain  between  the  groups.  In  all
the three  groups  the  tourniquet  pain  increased  signiﬁcantly
between 30  and  45  min  period.  This  is  in  correlation  with
the other  studies  that  suggest  under  regional  anaesthesia
tourniquet pain  usually  appears  about  45  min  after  inﬂation
and becomes  more  intense  with  time.15 Thus  both  of  the
adjuncts used  in  this  present  study  do  not  delay  or  reduce
the severity  of  intraoperative  tourniquet  pain  compared  to
the control.
The analgesic  consumption  for  treatment  of  early  post-
operative pain  was  signiﬁcantly  less  in  pethidine  and
ketoprofen group  compared  to  control.  The  time  for  ﬁrst
analgesic requirement  was  also  delayed  when  pethidine  and
ketoprofen were  used  as  adjuncts  when  compared  to  the
control. This  signiﬁes  that  pethidine  and  ketoprofen  provide
signiﬁcantly better  postoperative  analgesia  in  the  ﬁrst  6  h.
Both pethidine  and  ketoprofen  are  equally  efﬁcacious  in  pro-
viding postoperative  analgesia,  when  used  as  adjuncts  to
lignocaine in  IVRA.
Analgesic  consumption  was  not  signiﬁcantly  different
between 6  and  24  h  period  after  the  surgery.  Therefore
addition of  pethidine  or  ketoprofen  is  unlikely  to  provide
signiﬁcant analgesia  beyond  6  h.
In our  study  there  was  no  signiﬁcant  difference  in  the  inci-
dence of  side  effects  between  the  three  groups.  The  results
are in  contrast  to  high  incidence  of  side  effects  in  pethi-
dine group  in  Scott  Reuben’s  study.14 Two  of  the  forty-ﬁve
patients had  successful  block  in  our  study.  Thus  the  suc-
cess rate  was  95.56%.  This  is  close  to  96--100%  success  rate
described by  other  studies.16--18
Thus  we  conclude  that  addition  of  pethidine  or  keto-
profen as  adjuncts  in  IVRA  provides  signiﬁcantly  better
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ostoperative  analgesia  in  the  ﬁrst  6  h.  However  their
fﬁcacy postoperative  analgesia  is  limited  beyond  6  h.
ddition of  either  of  the  adjuncts  does  not  increase
he tourniquet  tolerance  when  compared  to  the  con-
rol group.  Neither  of  these  adjuncts  increases  the
ncidence of  side  effects  compared  to  the  control
roup.
We recommend  the  use  of  pethidine  30  mg  or  ketoprofen
00 mg  as  safe  and  effective  adjuncts  in  IVRA.
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